Key facts
- It has raised $1.7M; the latest was Early Stage VC ($1.7M) in Nov 2025.
- Notable investors include Agoranov, Daphni, Alain Decombe, Cercle de Chiron, FI8C — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for OWLO
- ·The full record, as it builds
Funding rounds
No funding rounds for OWLO are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OWLO
Developer of a next-generation microscopic technology intended to advance non-invasive imaging in healthcare. The company offers a patented 3d real-time visualization system based on artificial intelligence, compatible with existing microscopes and capable of deep tissue imaging, enabling clients to improve embryo selection, drug discovery, and medical diagnostics.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2024
- Employees
- 7
- Website
- owlo.io/
- Ownership
- Privately Held (backing)
OWLO doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OWLO shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OWLO in its N-PORT filings yet. We sweep new filings monthly.